000			02087 a2200529 4500
005			20250515152049.0
264		0	_c20090303
008			200903s 0 0 eng d
022			_a1744-6872
024	7		_a10.1097/FPC.0b013e32831665ea _2doi
040			_aNLM _beng _cNLM
100	1		_aLim, Yun-Ping
245	0	0	_aInhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4alpha interaction. _h[electronic resource]
260			_bPharmacogenetics and genomics _cJan 2009
300			_a11-24 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntifungal Agents _xpharmacology
650	0	4	_aBase Sequence
650	0	4	_aCell Line
650	0	4	_aCytochrome P-450 CYP3A _xgenetics
650	0	4	_aCytochrome P-450 CYP3A Inhibitors
650	0	4	_aDNA Primers _xgenetics
650	0	4	_aGene Expression Regulation, Enzymologic _xdrug effects
650	0	4	_aHeLa Cells
650	0	4	_aHepatocyte Nuclear Factor 4 _xantagonists & inhibitors
650	0	4	_aHistone Acetyltransferases _xantagonists & inhibitors
650	0	4	_aHumans
650	0	4	_aIn Vitro Techniques
650	0	4	_aKetoconazole _xpharmacology
650	0	4	_aLigands
650	0	4	_aNuclear Receptor Coactivator 1
650	0	4	_aPharmacogenetics
650	0	4	_aPregnane X Receptor
650	0	4	_aPromoter Regions, Genetic
650	0	4	_aProtein Interaction Domains and Motifs
650	0	4	_aRNA Interference
650	0	4	_aReceptors, Steroid _xantagonists & inhibitors
650	0	4	_aRecombinant Proteins _xantagonists & inhibitors
650	0	4	_aRifampin _xpharmacology
650	0	4	_aTranscription Factors _xantagonists & inhibitors
650	0	4	_aTwo-Hybrid System Techniques
700	1		_aKuo, Sheng-Chun
700	1		_aLai, Ming-Liang
700	1		_aHuang, Jin-Ding
773	0		_tPharmacogenetics and genomics _gvol. 19 _gno. 1 _gp. 11-24
856	4	0	_uhttps://doi.org/10.1097/FPC.0b013e32831665ea _zAvailable from publisher's website
999			_c18530237 _d18530237